PANROMYF
"PANROMYF" is no longer active. Dead trademarks are generally available to file, but you should verify no similar active marks exist in the same class before proceeding.
PANROMYF is registered to cover pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases.
Bristol-Myers Squibb Company is a mid-size portfolio holder with active trademark management, with 49 trademark filings on record (41 currently active), spanning 3 years of filing activity.
This application represents a pharmaceutical or dietary supplement brand (Class 5 — Pharmaceuticals), filed in November 2024.
These marks may compete in overlapping trademark classes. Consult an attorney before filing a similar brand.